Showing results (381-390 of 422) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2018
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid TumorsJason J Luke, Jeffrey M Lemons, Theodore G Karrison, et al.
The Oncologist|October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue SarcomasRodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
Journal of Translational Medicine|July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Annals of Surgical Oncology|February 1, 2025
Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 TrialCharles H Yoon, Merrick I Ross, Brian R Gastman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid TumorsCorey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I TrialJason J Luke, Benjamin E Onderdonk, Sandeep R Bhave, et al.
Pharmacoepidemiology and Drug Safety|April 30, 2026
The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in PregnancyHelen Dolk, Christine Damase-Michel, Joan Morris, et al.
Journal of Translational Medicine|September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
Royal Society Open Science|February 9, 2023
The process of replication target selection in psychology: what to consider?Merle-Marie Pittelkow, Sarahanne M Field, Peder M Isager, et al.
Pageof 43